Marty Driscoll Email

CEO . OncoNano Medicine

Current Roles

Employees:
33
Revenue:
$2.6M
About
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents. Our lead program, ONM-100, targets tumor acidosis to accurately differentiate cancer from healthy tissue for use in surgery.
OncoNano Medicine Address
550 Reserve St
Southlake, TX
United States
OncoNano Medicine Email

Past Companies

OncoNano Medicine, Inc.Chief Executive Officer
RIGImmune, Inc.Chairman
Spring Bank Pharmaceuticals, Inc.President & Chief Executive Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.